CPB CAMPBELL'S Co
Food and Kindred Products · Nasdaq · SEC CIK 16732 · Fiscal year ends 08/03
Financial factors as of 2026-08-02 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY-5.0%
TTM net income YoY-33.1%
TTM EPS YoY-34.8%
Revenue 3-yr CAGR1.4%
Net income 3-yr CAGR-22.3%
Margins
Gross margin28.1%
Operating margin8.7%
Net margin4.1%
FCF margin7.0%
EBITDA margin13.0%
Returns
ROE10.4%
ROA2.6%
ROIC (approx.)6.1%
Asset turnover0.64x
Leverage & solvency
Liabilities / assets73.4%
Debt / equity1.85x
Current ratio0.82x
Interest coverage2.57x
Cash quality & payout
Operating cash flow / net income2.58x
Accruals ratio-4.2%
Payout ratio116.6%
Capex / revenue3.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-08-02 | FY20252025-08-03 | FY20242024-07-28 | FY20232023-07-30 | FY20222022-07-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $9.74B | $10.25B | $9.64B | $9.36B | $8.56B |
| Cost of revenue | $7.00B | $7.13B | $6.67B | $6.44B | $5.93B |
| Gross profit | $2.74B | $3.12B | $2.97B | $2.92B | $2.63B |
| R&D expense | $99.00M | $100.00M | $102.00M | $92.00M | $87.00M |
| SG&A expense | $646.00M | $674.00M | $737.00M | $654.00M | $617.00M |
| Operating income | $852.00M | $1.12B | $1.00B | $1.31B | $1.16B |
| Interest expense | $331.00M | $345.00M | $249.00M | $188.00M | $189.00M |
| Pretax income | $529.00M | $796.00M | $757.00M | $1.13B | $975.00M |
| Income tax | $124.00M | $194.00M | $190.00M | $270.00M | $218.00M |
| Net income | $403.00M | $602.00M | $567.00M | $858.00M | $757.00M |
| EBITDA | $1.26B | $1.56B | $1.41B | $1.70B | $1.50B |
| EPS (basic) | 1.34 | 2.02 | 1.90 | 2.87 | 2.51 |
| EPS (diluted) | 1.31 | 2.01 | 1.89 | 2.85 | 2.51 |
| Dividends declared per share | 1.56 | 1.54 | 1.48 | 1.48 | 1.48 |
| Weighted avg. shares (diluted) | 300.00M | 300.00M | 300.00M | 301.00M | 302.00M |
| Balance sheet | |||||
| Cash & equivalents | $394.00M | $132.00M | $108.00M | $189.00M | $109.00M |
| Receivables | $517.00M | $541.00M | $587.00M | $494.00M | $490.00M |
| Inventory | $1.61B | $1.42B | $1.39B | $1.29B | $1.25B |
| Current assets | $2.72B | $2.23B | $2.19B | $2.06B | $1.96B |
| PP&E, net | $2.87B | $2.77B | $2.70B | $2.40B | $2.34B |
| Goodwill | $5.32B | $4.99B | $5.08B | $3.96B | $3.98B |
| Intangibles | $4.20B | $4.36B | $4.72B | $3.14B | $3.20B |
| Total assets | $15.65B | $14.90B | $15.23B | $12.06B | $11.89B |
| Current liabilities | $3.34B | $2.91B | $3.58B | $2.22B | $2.89B |
| Short-term debt | $977.00M | $762.00M | $1.42B | $191.00M | $814.00M |
| Long-term debt | $6.16B | $6.09B | $5.76B | $4.50B | $4.00B |
| Total debt | $7.14B | $6.86B | $7.18B | $4.69B | $4.81B |
| Total liabilities | $11.49B | $10.99B | $11.44B | $8.39B | $8.56B |
| Shareholders' equity | $3.85B | $3.90B | $3.79B | $3.66B | $3.33B |
| Net debt | $6.74B | $6.72B | $7.08B | $4.50B | $4.70B |
| Cash flow statement | |||||
| Operating cash flow | $1.04B | $1.13B | $1.19B | $1.14B | $1.18B |
| Capital expenditure | $361.00M | $426.00M | $517.00M | $370.00M | $242.00M |
| Free cash flow | $678.00M | $705.00M | $668.00M | $773.00M | $939.00M |
| Investing cash flow | -$357.00M | -$187.00M | -$3.13B | -$340.00M | -$230.00M |
| Financing cash flow | -$419.00M | -$919.00M | $1.86B | -$723.00M | -$910.00M |
| Depreciation & amortization | $413.00M | $434.00M | $411.00M | $387.00M | $337.00M |
| Stock-based compensation | $56.00M | $57.00M | $99.00M | $63.00M | $59.00M |
| Dividends paid | $470.00M | $459.00M | $445.00M | $447.00M | $451.00M |
| Share buybacks | $26.00M | $62.00M | $67.00M | $142.00M | $167.00M |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.